Systematic review and meta analysis of in situ fenestration and pre-fenestration in the treatment of thoracic aortic diseases
10.3760/cma.j.cn112434-20210327-00114
- VernacularTitle:原位开窗技术和预开窗技术治疗胸主动脉疾病的系统评价及荟萃分析
- Author:
Xiandong LIN
1
;
Ren WANG
;
Bin YOU
;
Huyu LIN
;
Jiaxiang ZHUANG
Author Information
1. 福建医科大学省立临床医学院 福建省立医院心外科，福州 350001
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2022;38(11):688-698
- CountryChina
- Language:Chinese
-
Abstract:
Thoracic aortic disease, which involves some of the arch vessels, is challenging to treat because of its complex anatomical structure and variation. With the progress and development of endovascular repair technology, in situ fenestration and pre-fenestration have become important measures for the treatment of thoracic aortic diseases. In recent years, there have been a series of reports on the application of in situ fenestration or pre-fenestration in a few centers, and the preliminary results are satisfactory. However, there are some problems such as single operation and small sample size. In order to further compare and analyze the safety and efficacy between the two operations, meta-analysis was conducted by searching Pubmed, Embase, Cochrane, Web of Science, China National Knowledge Infrastructure, Wanfang data, VIP data and China Biology Medicine disc. There was no significant difference in technical success rate, 30-day mortality, endoleak rate and reintervention rate between the two methods. The application of surgical methods can be determined according to the patient's condition and the surgeon's clinical experience.
